Virtu KCG Holdings’s EnteroMedics Inc. ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-12,936
Closed -$75K 4000
2017
Q1
$75K Sell
12,936
-508
-4% -$3.76K ﹤0.01% 2759
2016
Q4
$12K Sell
13,444
-26,642
-66% -$140K ﹤0.01% 3279
2016
Q3
$379K Buy
40,086
+39,326
+5,174% +$534K 0.01% 1673
2016
Q2
$15K Buy
760
+256
+51% +$11.7K ﹤0.01% 2827
2016
Q1
$34K Buy
504
+492
+4,100% +$39.8K ﹤0.01% 2530
2015
Q4
$2K Buy
+12
New +$2.49K ﹤0.01% 3434
2015
Q3
Sell
-46
Closed -$30K 4371
2015
Q2
$30K Sell
46
-29
-39% -$33.4K ﹤0.01% 3151
2015
Q1
$72K Buy
+75
New +$90.4K ﹤0.01% 2740
2014
Q4
Sell
-28
Closed -$35K 4720
2014
Q3
$35K Buy
28
+10
+56% +$14.7K ﹤0.01% 3411
2014
Q2
$31K Sell
18
-11
-38% -$20.6K ﹤0.01% 3490
2014
Q1
$54K Buy
+29
New +$68.7K ﹤0.01% 3325
2013
Q4
Sell
-153
Closed -$198K 4741
2013
Q3
$198K Buy
+153
New +$178K ﹤0.01% 3137

Other funds holding ETRM

Virtu KCG Holdings's ETRM Position: Q2 2017 in Review

Virtu KCG Holdings sold out of EnteroMedics Inc. (ETRM) in Q2 2017, closing a stake of 12,936 shares — an estimated $75K sold.

Virtu KCG Holdings first reported a position in ETRM in Q3 2013 and held it in 12 quarters. The position peaked at $379K in Q3 2016. 16 funds tracked by Wall St. Rank hold ETRM as of Q2 2017.

  • Virtu KCG Holdings reported no remaining EnteroMedics Inc. position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 12,936 EnteroMedics Inc. shares in Q2 2017, an estimated $75K.
  • Virtu KCG Holdings first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 12 quarters.
  • Virtu KCG Holdings's EnteroMedics Inc. position peaked at $379K in Q3 2016.
  • 16 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.